Tegoprazan India Launch, Acid Blocker

  Published 6 months ago

Tegoprazan, a next‑gen potassium‑competitive acid blocker, launches in India via Dr. Reddy's partnership with support.

  • Provides fast onset, prolonged gastric pH control, improving treatment for GERD, NERD, and ulcers effectively.
  • Approved in 21 countries, including South Korea and China, and completed the US Phase‑III trial successfully.
  • Collaboration merges Dr. Reddy's market strength with HK Inno. N's innovation, expanding patient access in India.

You might like these

Modi Unveils Big Reforms, Jobs, Chips

Tech Is a Strategic Differentiator: RBI

Tata Motors Invests $4.1B to Expand India Car Portfolio

Harsh Kundra Joins NIIT Digital as Head of Technology

NBCC Tapped for Postal Land Projects

Adani Green Q1: Revenue Soars 31%

Shakti Pumps Wins Rs 114.58 Cr Solar Pumping Contract

News that matters the most ⚡